One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Pharmaceuticals ➤ Automated Cell Counting Market
Automated Cell Counting Market
Automated Cell Counting Market
Published date: Dec 2024 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Pharmaceuticals ➤ Automated Cell Counting Market

Automated Cell Counting Market By Product Type (Consumables & Accessories and Instruments (Image-based Cell Counters, Flow Cytometers, and Electrical Impendence Coulter Counters)), By Application (Cell Line development (Biologics Production and Cell & Gene Therapy), Blood Analysis, Stem Cell Research, and Others), By End-use (Hospitals & Diagnostic laboratories, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Dec 2024
  • Report ID: 136148
  • Number of Pages: 361
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • Product Type Analysis
    • Application Analysis
    • End-use Analysis
    • Key Market Segments
    • Drivers
    • Restraints
    • Opportunities
    • Impact of Macroeconomic / Geopolitical Factors
    • Trends
    • Regional Analysis
    • Key Players Analysis
    • Recent Developments
    • Report Scope

    Report Overview

    The Global Automated Cell Counting Market size is expected to be worth around US$ 13 Billion by 2033, from US$ 4 Billion in 2023, growing at a CAGR of 12.5% during the forecast period from 2024 to 2033.

    Automated Cell Counting Market Size

    Increasing demand for precise and efficient cell analysis in medical research, diagnostics, and pharmaceutical applications is driving the growth of the automated cell counting market. Automated cell counting solutions offer significant advantages over traditional methods, including improved accuracy, high throughput, and reduced human error, making them essential in various applications such as cancer research, drug discovery, and infectious disease diagnostics.

    The growing need for rapid and reliable cell counts, especially in fields like oncology and virology, is creating new opportunities. For example, the World Health Organization (WHO) reported that approximately 39 million people globally were living with HIV by the end of 2022, highlighting the continued importance of accurate cell analysis in monitoring immune responses and treatment effectiveness.

    The trend toward personalized medicine and the increasing focus on cell-based therapies further fuel market expansion as automated cell counting technologies are used for cell culture, stem cell research, and gene therapy applications. Recent innovations in the field include the integration of artificial intelligence and machine learning to enhance the speed and precision of cell counting processes.

    Furthermore, the development of compact and user-friendly devices that offer multi-parameter analysis is opening up new opportunities for point-of-care applications, making automated cell counting accessible to a broader range of healthcare settings.

    Key Takeaways

    • In 2023, the market for Automated Cell Counting generated a revenue of US$ 4 billion, with a CAGR of 12.5%, and is expected to reach US$ 13 billion by the year 2033.
    • The product type segment is divided into consumables & accessories and instruments, with consumables & accessories taking the lead in 2023 with a market share of 67.4%.
    • Considering application, the market is divided into cell line development, blood analysis, stem cell research, and others. Among these, cell line development held a significant share of 49.5%.
    • Furthermore, concerning the end-use segment, the market is segregated into hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies, research & academic institutes, and others. The pharmaceutical & biotechnology companies sector stands out as the dominant player, holding the largest revenue share of 55.8% in the Automated Cell Counting market.
    • North America led the market by securing a market share of 39.8% in 2023.

    Product Type Analysis

    The consumables & accessories segment led in 2023, claiming a market share of 67.4% owing to the increasing demand for supporting products like reagents, filters, and counting slides, which are essential for the efficient operation of automated systems. These consumables are expected to witness rising adoption due to their critical role in maintaining the accuracy and functionality of automated cell counting instruments.

    The continuous advancements in cell counting technology and the growing use of automated systems in research and clinical laboratories are anticipated to fuel the need for consumables and accessories. Additionally, the regular replacement and replenishment of these consumables in high-throughput environments will likely contribute to the growth of this segment.

    The expanding focus on precision medicine and personalized healthcare, which requires regular and accurate cell analysis, is projected to further increase the demand for these supporting products. As more pharmaceutical and biotechnology companies incorporate automated cell counting into their workflows, the consumables and accessories segment is expected to benefit from their increasing reliance on these tools.

    Application Analysis

    The cell line development held a significant share of 49.5% due to the increasing importance of cell lines in drug development and biotechnology research. The demand for high-quality, reproducible cell lines in pharmaceutical research is projected to increase as companies focus on developing new therapies, particularly for cancer and genetic disorders.

    Automated cell counting plays a crucial role in the cell line development process, helping researchers maintain consistent cell growth, optimize culture conditions, and track cell proliferation. The growing emphasis on biologics and cell-based therapies is likely to further boost the demand for automated systems that provide precise and reliable cell counting.

    Additionally, the advancement of stem cell research, which relies heavily on cell line development, is expected to contribute significantly to this segment’s growth. The adoption of automated cell counting in cell line characterization and the increasing focus on improving cell culture efficiency are projected to drive substantial growth in this application segment.

    End-use Analysis

    The pharmaceutical & biotechnology companies segment had a tremendous growth rate, with a revenue share of 55.8% owing to the increasing reliance on automated systems for drug development, quality control, and clinical research. These companies are expected to integrate automated cell counting into their workflows to enhance efficiency, reduce human error, and ensure more accurate and reproducible results in cell analysis.

    The rising prevalence of chronic diseases and the growing focus on biologics, gene therapies, and personalized medicine are anticipated to drive the need for advanced cell counting solutions in pharmaceutical and biotechnology research. As these companies expand their R&D capabilities to develop novel therapeutics, the demand for automated systems that offer precise cell counting and analysis is likely to increase.

    Furthermore, regulatory pressures for accurate, consistent cell measurements in drug development and production are expected to push pharmaceutical and biotechnology companies towards adopting these automated solutions, leading to substantial growth in this segment.

    Automated Cell Counting Market Share

    Key Market Segments

    By Product Type

    • Consumables & Accessories
    • Instruments
      • Image-based Cell Counters
      • Flow Cytometers
      • Electrical Impendence Coulter Counters

    By Application

    • Cell Line development
      • Biologics Production
      • Cell & Gene Therapy
    • Blood Analysis
    • Stem Cell Research
    • Others

    By End-use

    • Hospitals & Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutes
    • Others

    Drivers

    Growing Prevalence Of Diabetes And Cancer

    Growing prevalence of diabetes and cancer significantly drives the automated cell counting market by increasing the demand for precise and efficient diagnostic tools. According to the World Health Organization (WHO), diabetes accounted for 1.5 million deaths globally in 2021, while cancer was responsible for 10 million deaths during the same period. These alarming statistics highlight the urgent need for accurate cell counting in disease diagnosis, monitoring, and treatment planning.

    Automated systems offer high accuracy and reproducibility, essential for detecting abnormal cell counts and ensuring timely medical interventions. Healthcare providers are expected to adopt these technologies to improve diagnostic workflows, reduce manual errors, and enhance patient outcomes. Furthermore, the rising incidence of these chronic diseases drives research and development efforts to innovate more advanced counting solutions.

    The integration of technologies such as flow cytometry and image analysis allows for detailed cellular analysis, crucial for personalized medicine approaches. Additionally, the scalability and efficiency of automated systems meet the growing laboratory demands, facilitating faster turnaround times for test results. As medical institutions strive to manage the increasing caseloads effectively, the adoption of these solutions is projected to rise.

    This trend not only supports clinical accuracy but also optimizes resource allocation within healthcare facilities, further fueling market growth. Moreover, the push towards digitalization in healthcare encourages the implementation of automated technologies, ensuring that the sector keeps pace with global health challenges.

    Restraints

    High Complexity Of Technology

    A significant restraint in the automated cell counting market is the high complexity of the underlying technology. Implementing advanced counting systems requires substantial technical expertise, which can be a barrier for many healthcare facilities. The sophisticated nature of these systems necessitates specialized training for laboratory personnel, increasing the operational costs and time required for effective utilization.

    Additionally, integrating automated solutions with existing laboratory information systems often involves complex configuration and customization, further complicating the adoption process. Maintenance and calibration of these high-tech instruments also present ongoing challenges, requiring regular professional service and support.

    Smaller laboratories and healthcare providers may find it difficult to justify the investment due to limited budgets and resources, limiting the market penetration of these technologies. Moreover, the rapid pace of technological advancements can render existing systems obsolete quickly, compelling continuous investment in upgrades and new models.

    This technological complexity not only increases the initial and operational costs but also affects the overall accessibility of automated cell counting solutions. As a result, the high complexity associated with these systems restrains widespread adoption and slows down market growth, particularly in regions with limited technical infrastructure.

    Opportunities

    Increasing R&D Activities Is Creating Opportunities

    Increasing research and development activities create substantial opportunities for the automated cell counting market by fostering innovation and the introduction of advanced technologies. In March 2023, UCLA’s Stem Cell Research and the Eli & Edythe Broad Center for Regenerative Medicine secured over USD 5.7 million in funding from the California Institute for Regenerative Medicine to advance stem cell-based solutions for cancer treatment and addressing intellectual disabilities.

    These investments drive the development of more sophisticated counting systems capable of handling complex analyses required in cutting-edge medical research. Enhanced R&D efforts lead to the creation of more accurate, efficient, and user-friendly automated counters, meeting the evolving needs of healthcare professionals and researchers.

    Furthermore, collaboration between academic institutions and industry players accelerates the innovation cycle, resulting in the commercialization of breakthrough technologies. The integration of artificial intelligence and machine learning in counting systems, a focus of ongoing research, promises to improve data analysis and predictive capabilities.

    Additionally, R&D activities focused on miniaturization and portability make automated systems more accessible to diverse healthcare settings, including remote and resource-limited environments. As research continues to push the boundaries of what automated counting can achieve, the market is anticipated to experience significant growth driven by these technological advancements. Increased funding and supportive policies for medical research further bolster the potential for market expansion, enabling the development of next-generation counting solutions that enhance diagnostic precision and efficiency.

    Impact of Macroeconomic / Geopolitical Factors

    Macroeconomic and geopolitical factors exert a significant influence on the automated cell counting market. On the positive side, the increasing demand for advanced medical research, biotechnology, and pharmaceutical development fuels the adoption of automated cell counters. Economic growth, especially in emerging markets, provides healthcare institutions with more resources to invest in sophisticated laboratory equipment.

    However, economic downturns can lead to budget cuts, delaying investments in high-cost technology. Geopolitical factors such as trade regulations and international healthcare policies can disrupt the supply chain for essential components, raising costs. Additionally, regulatory uncertainties surrounding healthcare devices and technology can pose challenges.

    Despite these concerns, the growing focus on precision medicine, research in oncology, and drug development is expected to propel market growth, with innovation continuing to drive the sector forward.

    Trends

    Surge in Launch of Hi-tech and Sophisticated Cell Counters Driving the Market

    Rising interest in high-tech and sophisticated cell counters is accelerating the growth of the automated cell counting market. Advances in cell counting technology are expected to improve the accuracy, efficiency, and throughput of laboratory operations. The demand for devices that offer higher precision, faster results, and user-friendly interfaces is increasing across research, clinical, and pharmaceutical settings.

    In August 2022, DeNovix Inc. launched two specialized nuclei counting applications for its CellDrop Automated Cell Counters, designed to differentiate isolated nuclei and intact cells from debris effectively. These innovations are anticipated to drive further interest in automated systems, offering researchers more powerful tools to support advanced studies. As the need for more accurate diagnostics and cell analysis increases, the market is projected to continue expanding in response to technological advancements.

    Regional Analysis

    North America is leading the Automated Cell Counting Market

    North America dominated the market with the highest revenue share of 39.8% owing to increasing demand from the biotechnology and pharmaceutical sectors. The rise in research activities related to cell biology, immunology, and drug development has spurred the adoption of automated cell counting technologies, as they offer enhanced accuracy, efficiency, and reproducibility compared to traditional manual methods.

    One notable development in January 2023 was the launch of the Omni Pro 12 by Axion BioSystems, which provides automated solutions for multiple users and supports live-cell imaging applications. The product’s ability to streamline workflows in labs has been particularly appealing to researchers, contributing to the overall growth of the market.

    Moreover, the increasing focus on personalized medicine and cell-based therapies, which require precise and scalable cell counting solutions, has further bolstered the market demand. The need for faster and more reliable results in clinical and preclinical studies has driven pharmaceutical companies to adopt these advanced technologies, ensuring sustained growth in the region.

    The Asia Pacific region is expected to experience the highest CAGR during the forecast period

    Asia Pacific is expected to grow with the fastest CAGR owing to advancements in healthcare infrastructure and research. As the region experiences rapid improvements in medical research and biotechnology, the demand for automated cell counting solutions is expected to increase, particularly in countries like China, India, and Japan.

    The growing investment in cell therapy and regenerative medicine is likely to drive the need for efficient and accurate cell counting methods. Additionally, the increasing prevalence of chronic diseases and cancer in the region is anticipated to spur the demand for advanced diagnostic tools, further boosting market growth.

    Governments’ support for research and development in life sciences and the expansion of clinical trials in emerging markets are estimated to contribute to the market’s expansion. The rising adoption of automation in laboratories, coupled with the growing emphasis on reducing human error and increasing throughput, is likely to drive the uptake of automated cell counting technologies across the region.

    Automated Cell Counting Market Regions

    Key Regions and Countries

    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Russia
      • Netherland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • Australia
      • New Zealand
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA

    Key Players Analysis

    Key players in the automated cell counting market focus on strategies such as developing advanced imaging and AI-based technologies to improve accuracy and efficiency in cell analysis. Companies expand their product portfolios by offering versatile devices capable of handling various cell types and applications. Strategic collaborations with research institutions and biotechnology firms enable them to drive innovation and cater to evolving market demands.

    Investments in user-friendly software and digital integration enhance operational efficiency, while global expansion into emerging markets helps increase their customer base. Emphasis on compliance with stringent regulatory standards ensures their solutions remain competitive and reliable.Thermo Fisher Scientific Inc. is a prominent player in the automated cell counting market, offering advanced instruments like the Countess series.

    The company combines cutting-edge imaging technologies with robust software to deliver accurate and fast cell counting solutions. Thermo Fisher focuses on addressing diverse research and clinical needs, supported by its extensive global presence and commitment to innovation.

    Top Key Players in the Automated Cell Counting Market

    • Sysmex Corporation
    • Olympus Corporation
    • MERCK KGaA
    • HORIBA
    • DeNovix Inc.
    • Danaher
    • Chemometec A/S
    • Thermo Fisher Scientific
    • Abbott

    Recent Developments

    • In July 2024: DeNovix Inc. introduced a hepatocyte counting application within the CellDrop software. This innovative tool, powered by a machine learning algorithm, is tailored for precise cell counting. The budget-friendly CellDrop software, accessible to all laboratories, is the first of its kind. By eliminating the need for cartridges or disposable slides, it significantly reduces both costs and plastic waste.
    • In October 2023: DeNovix’s CellDrop Automated Cell Counter earned ACT Label certification from My Green Lab, becoming the first automated cell counter to receive this recognition under the program.
    • In October 2022: Thermo Fisher Scientific launched innovative closed and automated solutions for cell isolation and bead removal. These advancements aim to enhance cell therapy manufacturing by improving cell purity, isolation efficiency, and target cell recovery, enabling scalability in production processes.

    Report Scope

    Report Features Description
    Market Value (2023) US$ 4.0 billion
    Forecast Revenue (2033) US$ 13.0 billion
    CAGR (2024-2033) 12.5%
    Base Year for Estimation 2023
    Historic Period 2019-2022
    Forecast Period 2024-2033
    Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments Covered By Product Type (Consumables & Accessories and Instruments (Image-based Cell Counters, Flow Cytometers, and Electrical Impendence Coulter Counters)), By Application (Cell Line development (Biologics Production and Cell & Gene Therapy), Blood Analysis, Stem Cell Research, and Others), By End-use (Hospitals & Diagnostic laboratories, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Others)
    Regional Analysis North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe; Asia Pacific – China, Japan, South Korea, India, Australia, New Zealand, Singapore, Thailand, Vietnam, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of MEA
    Competitive Landscape Sysmex Corporation, Olympus Corporation, MERCK KGaA, HORIBA, F. Hoffmann-La Roche Ltd, Danaher, Chemometec A/S, Bio-Rad Laboratories, Inc, and Abbott.
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
    Automated Cell Counting Market
    Automated Cell Counting Market
    Published date: Dec 2024
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Sysmex Corporation
    • Olympus Corporation
    • Merck KGaA Company Profile
    • HORIBA
    • DeNovix Inc.
    • Danaher Corporation Company Profile
    • Chemometec A/S
    • Thermo Fisher Scientific Company Profile
    • Abbott Laboratories
  • settingsSettings

Related Reports

  • CAR-T Cell Therapies Market
  • Autologous Cell Therapy Market
  • 3D Cell Culture Market
  • Stem Cell Therapy Market
  • Cell Counting Market
  • Live Cell Imaging Market
  • Cell and Gene Therapy Market
  • Cell Therapy Market
  • Cell Culture Market
  • Cell Therapy Monitoring Kits Market

Our Clients

  • Our Clients
Inquiry Before Buying

Automated Cell Counting Market
  • 136148
  • Dec 2024
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.